Francoise Dixon
Head of Investor Relations
Good morning, and welcome to the Mach7 Q1 FY ’27 Result Briefing. My name is Francoise Dixon, and I’m Head of Investor Relations for Mach7. Today, our CEO, Teri Thomas; and CFO, Shawni Hadfield, will provide an overview of our Q1 results. We will then open it up for questions. [Operator Instructions]
I’ll now hand over to Teri.
Teri Thomas
CEO, MD & Director
Thank you, Francoise. Good morning, everyone, and thank you for joining us. Mach7 has now delivered 4 consecutive quarters of positive operating cash flow. We’ve grown ARR 8.5% in constant currency, and we are just a few weeks away showing a new product suite at our biggest conference, RSNA. I am delighted to be here with Shawni Hadfield, now officially our CFO. Shawni, so good to be able to drop the word interim. We have strengthened our foundation and our recurring revenue base is growing. We’re also broadening what our technology can do for customers and innovating, creating new modules.
So today, I’ll show you how we’re putting this together into a stronger foundation from which to work. Standard disclaimer about forward-looking statements, dollar figures are in Australian dollars and the quarterly financial information that we are sharing is unaudited. Now for those of you who don’t know us, Mach7 software helps health care organizations to store, view and share many types of medical images. We’re connecting those images closely to the clinical work and the electronic health record, while keeping customers in control of their data, something that will be more and more important in a future in which AI plays a greater
